store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eribulin mesylate (E7389 mesylate) (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 430.00 | |
5 mg | In stock | $ 597.00 | |
10 mg | In stock | $ 828.00 | |
25 mg | In stock | $ 1,230.00 | |
50 mg | In stock | $ 1,660.00 |
Description | Eribulin mesylate (E7389 mesylate) (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer. |
Synonyms | B1939 mesylate, ER-086526 mesylate, E7389 mesylate |
Molecular Weight | 826 |
Formula | C41H63NO14S |
CAS No. | 441045-17-6 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 98 mg/mL (118.64 mM)
DMSO: 98 mg/mL (118.64 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eribulin mesylate 441045-17-6 Apoptosis Cytoskeletal Signaling Others Microtubule Associated E7389 Mesylate ER 086526 E-7389 Eribulin metastatic B1939 Inhibitor B1939 mesylate inhibit E 7389 Mesylate breast Microtubule/Tubulin cancer B 1939 Mesylate E7389 B 1939 B-1939 Mesylate B1939 Mesylate B-1939 Eribulin Mesylate microtubule E-7389 Mesylate E 7389 ER-086526 ER086526 Mesylate ER 086526 Mesylate ER-086526 mesylate ER-086526 Mesylate ER086526 E7389 mesylate inhibitor